|
the silence of the mgmt indicates...
|
10
|
Resverlogix Corp.
|
Mar 19, 2021 05:49PM
|
|
RVX's place in therapy - future prediction
|
7
|
Resverlogix Corp.
|
Mar 13, 2021 10:28AM
|
|
Re: Vaccines are here. That’s no reason to call off the hunt for effective COVID-19 treatments. Article from Market Watch...good read.
|
8
|
Resverlogix Corp.
|
Mar 19, 2021 08:22PM
|
|
Re: Vaccines are here. That’s no reason to call off the hunt for effective COVID-19 treatments. Article from Market Watch...good read.
|
7
|
Resverlogix Corp.
|
Mar 19, 2021 08:55PM
|
|
Re: Time keeps ticking
|
3
|
Resverlogix Corp.
|
Nov 19, 2021 01:24PM
|
|
Re: Those are some great stats, but unfortunately not ours.
|
9
|
Resverlogix Corp.
|
Jan 15, 2022 03:09PM
|
|
Re: The BET Protein Inhibitor Apabetalone Rescues Diabetes-induced Impairment of Angiogenic Response by Epigenetic Regulation of Thrombospondin-1
|
5
|
Resverlogix Corp.
|
Dec 21, 2021 08:42PM
|
|
Re: Study results?
|
5
|
Resverlogix Corp.
|
Mar 07, 2022 11:56AM
|
|
Re: RVX's place in therapy - future prediction
|
3
|
Resverlogix Corp.
|
Mar 15, 2021 09:10AM
|
|
Re: RVX's place in therapy - future prediction
|
5
|
Resverlogix Corp.
|
Mar 13, 2021 03:50PM
|
|
Re: RVX 2023 valuation attempt using Moderna metrics
|
11
|
Resverlogix Corp.
|
Jan 30, 2022 12:28PM
|
|
Re: Resverlogix: The Future of Drug Development, CEO Clip Video
|
3
|
Resverlogix Corp.
|
Dec 16, 2021 06:25PM
|
|
Re: Response
|
2
|
Resverlogix Corp.
|
Jan 23, 2024 12:59PM
|
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
6
|
Resverlogix Corp.
|
Nov 29, 2021 07:45PM
|
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
1
|
Resverlogix Corp.
|
Nov 29, 2021 07:52PM
|
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
7
|
Resverlogix Corp.
|
Nov 29, 2021 11:31PM
|
|
Re: Long term risks associated with covid
|
1
|
Resverlogix Corp.
|
Jan 06, 2022 10:03AM
|
|
Re: Long Covid
|
5
|
Resverlogix Corp.
|
Jan 22, 2024 10:37AM
|
|
Re: Long Covid
|
6
|
Resverlogix Corp.
|
Jan 22, 2024 03:23PM
|
|
Re: Long Covid
|
5
|
Resverlogix Corp.
|
Jan 22, 2024 03:40PM
|
